Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.27 USD | -1.55% | -10.56% | -5.22% |
04-24 | Precigen, Inc. to Present Late-Breaking Abstract for Pivotal Phase 2 Study Data for PRGN- 2012 AdenoVerse Immunotherapy | CI |
03-25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.22% | 321M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- PGEN Stock
- News Precigen, Inc.
- JPMorgan Initiates Precigen at Neutral Rating